Article

Heidi Gottlieb Gives Advice to Brain Tumor Patients and Survivors

Author(s):

Heidi Gottlieb

Heidi Gottlieb, a brain tumor survivor and the director and founder of Brain Matters, gives advice to other patients and survivors.

Heidi Gottlieb, a brain tumor survivor and the director and founder of Brain Matters, gives advice to other patients and survivors.

Heidi told us her story at at I Had Cancer's "A Celebration of Shared Experiences Honoring You."

Learn more about Heidi at brain-matters.org

Newsletter

Stay up to date on cancer updates, research and education

Subscribe Now!
Related Videos
Image of two doctors and text.
New Treatment Options Emerging for Across Lung Cancer Subtypes
Image of patient and doctor.
Understanding the Whole Person Behind their Cancer Diagnosis
Image of two doctors with text.
Delving Into Brain Cancer Treatment Takeaways Following ASCO 2025
image of gerds
Breaking Down the VERIFY Trial for Patients With Polycythemia Vera
Image of 2 doctors and text.
What Should Patients With Lung Cancer Know After ASCO 2025?
Image of two doctors and text.
Bringing Light to More Personalized Medicine in Lung Cancer After ASCO 2025
Image of man.
A New Therapeutic Approach May Make Waves in Kidney Cancer Treatment
Image of thumbnail.
What Patients With Genitourinary Cancers Should Know After ASCO 2025
Patients can prepare personal overviews to help care teams connect with them as individuals, explained Michelle Kirschner in an interview with CURE.
How to Prepare for Self-Advocacy After a Cancer Diagnosis
Enhertu with Perjeta nearly doubled progression-free survival versus standard treatment in metastatic HER2-positive breast cancer, study shows.
Enhertu Combo May Offer Longer Control for HER2+ Breast Cancer
Related Content
Image of brain
June 16th 2025

Explaining Brain Cancer and Metastases Updates for Patients

Ryan Scott
The 2025 ASCO Annual Meeting highlighted key advances in brain cancer and brain metastases for patients affected by the disease.
Site Logo
August 29th 2019

Earning Your Legacy: Cancer Has Nothing To Do With It

Kristie L. Kahl
In this episode of the “CURE Talks Cancer” podcast, we spoke with Matt Newman, who was diagnosed with brain cancer at 39, but refuses to let cancer define the legacy he has made.
Younger patients with grade 3 oligodendroglioma have fewer molecular abnormalities and longer survival than older patients: © stock.adobe.com.
May 19th 2025

Study Reveals Distinct Outcomes in Younger Patients With Grade 3 Oligodendroglioma

Spencer Feldman
Younger patients with grade 3 oligodendroglioma have fewer molecular abnormalities and longer survival than older patients, a study found.
Site Logo
April 11th 2019

Addressing Nutritional Needs in Cancer

Kristie L. Kahl
In this week’s episode, we spoke with the founder and CEO of Savor Health on the importance of nutrition for patients and caregivers before, during and after cancer treatment.
Danyelza is now a recommended treatment in NCCN guidelines for high-risk neuroblastoma: © sudok1 - stock.adobe.com.
May 8th 2025

Danyelza Added to NCCN Guidelines for High-Risk Neuroblastoma

Spencer Feldman
Danyelza is now a recommended treatment in NCCN guidelines for relapsed or refractory high-risk neuroblastoma, a type of brain cancer.
Dr. Suresh S. Ramalingam explains that patients with stage 3 lung cancer who undergo chemotherapy and radiation may develop radiation pneumonitis.
May 7th 2025

Managing Lung Inflammation After Chemoradiation and Tagrisso

Dr. Suresh S. Ramalingam
Dr. Suresh S. Ramalingam explains that patients with stage 3 lung cancer who undergo chemotherapy and radiation may develop radiation pneumonitis.